Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia.
about
HIF2α-arginase axis is essential for the development of pulmonary hypertension.Pharmacokinetics and Pharmacodynamics of Promising Arginase Inhibitors.Arginase Inhibitors: A Rational Approach Over One Century.Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension.Plasmatic Concentrations of ADMA and Homocystein in Llama (Lama glama) and Regulation of Arginase Type II: An Animal Resistent to the Development of Pulmonary Hypertension Induced by Hypoxia.
P2860
Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia.
@en
Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia.
@nl
type
label
Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia.
@en
Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia.
@nl
prefLabel
Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia.
@en
Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia.
@nl
P2093
P2860
P1476
Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia.
@en
P2093
ChunYan Xing
HongChao Wang
PingDong Jia
WeiDong Qin
WenBin Gong
XiaoYing XiangLi
YanBiao Chu
P2860
P2888
P356
10.1007/S11010-015-2611-Z
P577
2015-11-25T00:00:00Z